In addition to increases in HIF-1 observed in lung cancer cells [18–20], hypoxia and up-regulated HIF-1α have been shown in airway tissues obtained from human smokers with COPD [19], suggesting a potential role for inflammation-mediated hypoxia and HIF-1 pathway activation in the progression from COPD to lung cancer. This evidence concerns the gene HIF1A and lung carcinoma.